Back to results
RecruitingPhase 2

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

NCT06179303

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Siteman Cancer Center at Washington University

St Louis, Missouri, United States

+1 additional location

Contact

Hannah Linden

206-606-2053hmlinden@uw.edu
View on ClinicalTrials.gov
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer — TrialFind